HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

crisamicin B

from Micromonospora purpureochromogenes

Also Known As:

CRS-B; Crisamicin B

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        Naphthoquinones: 418
        crisamicin B: 2
- Quinones: 434
  - Naphthoquinones: 418
    - crisamicin B: 2
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - Naphthoquinones: 418
      - crisamicin B: 2

Experts

1.	Cao, Shougen: 1 article (05/2018)
2.	Chen, Dong: 1 article (05/2018)
3.	Chen, Yufan: 1 article (05/2018)
4.	Gao, Chao: 1 article (05/2018)
5.	Ji, Jiafu: 1 article (05/2018)
6.	Jiang, Haitao: 1 article (05/2018)
7.	Jin, Chenggen: 1 article (05/2018)
8.	Li, Yu: 1 article (05/2018)
9.	Li, Ziyu: 1 article (05/2018)
10.	Liu, Xiaodong: 1 article (05/2018)

Related Diseases

1.	Stomach Neoplasms (Stomach Cancer) 05/25/2018 - "The clinicopathological features and treatment were compared between CRS after benign disease operation (CRS-B) group and CRS after gastric cancer operation (CRS-C) group, and factors influencing prognosis were analyzed using Cox regression model analysis. "
2.	Neoplasms (Cancer) 05/25/2018 - "As compared to the CRS-C group, the CRS-B group has higher percentage of male, longer interval, larger tumor diameter and later TNM stage. " 05/25/2018 - "Compared to CRS-C group, CRS=B group had higher ratio of male [92.6% (100/108) vs. 81.7% (89/109), χ2=5.779, P=0.016], longer interval [30(25-40) years vs. 4(1.5-8.0) years, Z=-1.685, P=0.000], longer tumor diameter [(5.9±3.2) cm vs. (3.9±2.4) cm, t=3.390, P=0.000] and later tumor stage [patients in stage I(, II(, III(, and IIII(: 6 (8.0%), 14 (18.7%), 41 (54.7%), and 14 (18.7%) vs. 16 (25.4%), 14 (22.2%), 21(33.3%), and 12(19.0%), respectively, Z=-2.018, P=0.044]. "
3.	Carcinoma (Carcinomatosis) 05/25/2018 - "In CRS-B group, location of stump carcinoma in gastric intestinal anastomosis, gastric anastomosis, and non-anastomosis area was found in 60.9%(28/46), 23.9%(11/46) and 15.2%(7/46) respectively, and the corresponding percentage in CRS-M group was 39.5%(17/43), 16.3%(7/43) and 44.2%(19/43) respectively without significant difference (χ2=4.726, P=0.096). "

Related Drugs and Biologics

1.	crisamicin C